[Report] Beyond the Breakthrough: Turning Oncology Guidelines into Clinical Reality
October 7, 2025
Survey insights from 150 oncologists in the UK, France, and Germany on the barriers and opportunities in guideline adoption.
A medical breakthrough truly becomes impactful when it reaches the patient. Our new report reveals the gap between oncology guideline publication and adoption in clinical practice, and what can be done to close it.
Inside the report you’ll find:
- How often oncologists use guidelines (66% daily, 88% ESMO specifically)
- Why nearly half delay adoption until local policies update
- The biggest barriers to adoption: time, training, institutional restrictions and consensus
- Key differences across the UK, France and Germany
- Oncologists’ cautious optimism about AI-powered guideline tools
- A practical playbook to support clear communication, consistent visibility and ongoing measurement
- The role of patient advocacy in accelerating adoption
Download the Report
Discover the data and strategies shaping the last mile of oncology innovation.
Real Chemistry at ESMO 2025
Real Chemistry will be in Berlin for this year’s ESMO Congress to connect with the oncology leaders that are shaping the future of cancer care and sharing their groundbreaking discoveries and cutting-edge treatments.
Ahead of this year’s event, we invite you to connect with our team. Reach out to us at events@realchemistry.com or submit the form here.
